Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Cited by (885)

Items 101–200 of 885

1. Identification of Direct Protein Targets of Small Molecules
   Brett Lomenick, Richard W. Olsen, Jing Huang · 2010 · ACS Chemical Biology
2. Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer
   Susan E. Morgan, Michael B. Kastan · 1997 · Advances in cancer research
3. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
   Joseph Avruch, Kenta Hara, Yenshou Lin, Mingxiang Liu, X Long, Sara Ortiz-Vega, Kazuyoshi Yonezawa · 2006 · Oncogene
4. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis
   Cristina Cerboni, Alessandra Zingoni, Marco Cippitelli, Mario Piccoli, Luigi Frati, Angela Santoni · 2007 · Blood
5. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
   Allan S. MacDonald, Joseph A. Scarola, James T. Burke, James J. Zimmerman · 2000 · Clinical Therapeutics
6. The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1
   Chou, Margaret M, Blenis, John · 1996 · Cell
7. Metformin as an Anticancer Agent
   Vancura, Ales, Bu, Pengli, Bhagwat, Madhura, Zeng, Joey, Vancurova, Ivana · 2018 · Trends in Pharmacological Sciences
8. Control of Ser2448 Phosphorylation in the Mammalian Target of Rapamycin by Insulin and Skeletal Muscle Load
   Thomas Reynolds, Sue C. Bodine, John C. Lawrence · 2002 · Journal of Biological Chemistry
9. The Role of mTOR Signaling as a Therapeutic Target in Cancer
   N. V. Popova, Manfred Jücker · 2021 · International Journal of Molecular Sciences
10. Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
    Shile Huang, Hongyu Zhou · 2011 · Current Protein and Peptide Science
11. Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
    Zhou Zhu, Chuanbin Yang, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, Sravan Gopalkrishnashetty Sreenivasmurthy, Jia Liu, Ziying Wang, Benjamin Chun‐Kit Tong, Ju‐Xian Song, Jiahong Lu et al. · 2019 · International Journal of Molecular Sciences
12. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Birgit Geoerger, Karol Kerr, C B Tang, Kar‐Ming Fung, B Powell, Leslie N. Sutton, Peter C. Phillips∥, Anna J. Janss · 2001 · PubMed
13. mTOR signaling in skeletal development and disease
    Jianquan Chen, Fanxin Long · 2018 · Bone Research
14. Industrial natural product chemistry for drug discovery and development
    Armin Bauer, Mark Brönstrup · 2013 · Natural Product Reports
15. Molecular mechanisms for the control of translation by insulin
    Christopher G. Proud, M. Richard DENTON · 1997 · Biochemical Journal
16. Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation
    Anke Klippel, Maria-Amelia Escobedo, Matthew S. Wachowicz, Gerald Apell, Timothy W. Brown, Martin A Giedlin, W. Michael Kavanaugh, Lewis T. Williams · 1998 · Molecular and Cellular Biology
17. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes
    Sinars, Cindy R., Cheung-Flynn, Joyce, Rimerman, Ronald A., Scammell, Jonathan G., Smith, David F., Clardy, Jon · 2003 · Proceedings of the National Academy of Sciences
18. Rapamycin: an anti-cancer immunosuppressant?
    Law, Brian K. · 2005 · Critical Reviews in Oncology/Hematology
19. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
    Sarbassov, Dos D., Sabatini, David M. · 2005 · Journal of Biological Chemistry
20. Newer Immunosuppressive Drugs
    Jan Fritz Gummert, Tuija S Ikonen, Randall Ellis Morris · 1999 · Journal of the American Society of Nephrology
21. The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy
    Robert T. Abraham, James J. Gibbons · 2007 · Clinical Cancer Research
22. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
    Amornphimoltham, Panomwat, Patel, Vyomesh, Sodhi, Akrit, Nikitakis, Nikolaos G., Sauk, John J., Sausville, Edward A., Molinolo, Alfredo A., Gutkind, J. Silvio · 2005 · Cancer Research
23. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling
    Margaret M. Chou, John Blenis · 1995 · Current Opinion in Cell Biology
24. Control of PHAS-I by Insulin in 3T3-L1 Adipocytes
    Tai-An Lin, Xianming Kong, Alan R. Saltiel, Perry J. Blackshear, John C. Lawrence · 1995 · Journal of Biological Chemistry
25. TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin
    Michael C. Lorenz, Joseph Heitman · 1995 · Journal of Biological Chemistry
26. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.
    Sabine R. von Manteuffel, Anne‐Claude Gingras, Xiu‐Fen Ming, Nahum Sonenberg, George Thomas · 1996 · Proceedings of the National Academy of Sciences
27. mTOR Signaling
    Mathieu Laplante, David M. Sabatini · 2011 · Cold Spring Harbor Perspectives in Biology
28. TOR Signaling
    Thurl E. Harris, John C. Lawrence · 2003 · Science s STKE
29. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
    Lorina Dudkin, Michael B. Dilling, Pamela J. Cheshire, Franklin C. Harwood, Melinda G. Hollingshead, Susan G. Arbuck, R Travis, Edward A. Sausville, Peter J. Houghton · 2001 · PubMed
30. mTOR: a protein kinase switching between life and death
    Laura Asnaghi, Paolo Bruno, Marcella Priulla, Angelo Nicolin · 2004 · Pharmacological Research
31. The Insulin-Induced Signalling Pathway Leading to S6 and Initiation Factor 4E Binding Protein 1 Phosphorylation Bifurcates at a Rapamycin-Sensitive Point Immediately Upstream of p70 s6k
    Sabine R. von Manteuffel, Patrick B. Dennis, Nick Pullen, Anne‐Claude Gingras, Nahum Sonenberg, George Thomas · 1997 · Molecular and Cellular Biology
32. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.
    Wen‐Chen Yeh, Barbara E. Bierer, Steven Lanier McKnight · 1995 · Proceedings of the National Academy of Sciences
33. Human Cytomegalovirus Up-Regulates the Phosphatidylinositol 3-Kinase (PI3-K) Pathway: Inhibition of PI3-K Activity Inhibits Viral Replication and Virus-Induced Signaling
    Robert A. Johnson, Xin Wang, Xiuli Ma, Shu‐Mei Huong, Eng‐Shang Huang · 2001 · Journal of Virology
34. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes
    Gunter S. Fischer, Tobias Aumüller · 2003 · Springer eBooks
35. Immunophilins and Parvulins. Superfamily of Peptidyl Prolyl Isomerases in Arabidopsis
    Zengyong He, Legong Li, Sheng Luan · 2004 · PLANT PHYSIOLOGY
36. Research progress of mTOR inhibitors
    Yifan Chen, Xiao‐Ping Zhou · 2020 · European Journal of Medicinal Chemistry
37. Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
    James J. Gibbons, Robert T. Abraham, Ker Yu · 2009 · Seminars in Oncology
38. The Translational Regulation in mTOR Pathway
    Miaomiao Yang, Yanming Lu, Weilan Piao, Hua Jin · 2022 · Biomolecules
39. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies
    Amit W. Panwalkar, Srđan Verstovšek, Francis Joseph Giles · 2004 · Cancer
40. Proximity-Based Modalities for Biology and Medicine
    Xingui Liu, Alessio Ciulli · 2023 · ACS Central Science
41. Accelerated wound healing by mTOR activation in genetically defined mouse models
    Squarize, Cristiane H., Castilho, Rogerio M., Bugge, Thomas H., Gutkind, J. Silvio · 2010 · PLoS ONE
42. SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION
    Christopher J.E. Watson, Peter John Friend, Neville V. Jamieson, Thomas W. Frick, Graeme Alexander, Alexander E. Gimson, Roy Calne · 1999 · Transplantation
43. Chasing molecular glue degraders: screening approaches
    Domostegui, Ana, Nieto-Barrado, Luis, Perez-Lopez, Carles, Mayor-Ruiz, Cristina · 2022 · Chemical Society Reviews
44. Unifying principles of bifunctional, proximity-inducing small molecules
    Gerry, Christopher J., Schreiber, Stuart L. · 2020 · Nature Chemical Biology
45. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways
    Kathleen A. Martin, John Blenis · 2002 · Advances in cancer research
46. Cytoplasmic–nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation
    Jae Eun Kim, Jie Chen · 2000 · Proceedings of the National Academy of Sciences
47. Neural actions of immunophilin ligands
    Solomon H. Snyder, David M. Sabatini, Michael Min-Shyue Lai, Joseph P. Steiner, Gregory S. Hamilton, Peter D. Suzdak · 1998 · Trends in Pharmacological Sciences
48. Phospholipase D confers rapamycin resistance in human breast cancer cells
    Yuhong Chen, Zheng Yang, David A. Foster · 2003 · Oncogene
49. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
    Akrit Sodhi, Risa Chaisuparat, Jiadi Hu, Amanda K. Ramsdell, Brendan D. Manning, Edward A. Sausville, Earl T. Sawai, Alfredo Molinolo, Jorge Silvio Gutkind, Silvia Montaner · 2006 · Cancer Cell
50. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling
    Robert T. Abraham · 1998 · Current Opinion in Immunology
51. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
    Timothy R. Brazelton, Randall Ellis Morris · 1996 · Current Opinion in Immunology
52. mTOR signaling in stem and progenitor cells
    Delong Meng, Anderson R. Frank, Jenna L. Jewell · 2018 · Development
53. mTOR inhibitors: An overview
    Peter Neuhaus, J Klupp, Jan Michael Langrehr · 2001 · Liver Transplantation
54. Identification of Phosphorylation Sites in the Translational Regulator, PHAS-I, That Are Controlled by Insulin and Rapamycin in Rat Adipocytes
    Patrick Fadden, Timothy Haystead, John C. Lawrence · 1997 · Journal of Biological Chemistry
55. A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor
    Elsa Lam, Mary M. Martin, Anthony P. Timerman, Candace J. Sabers, Sidney Fleischer, Thomas J. Lukas, Robert T. Abraham, Stephen J. O’Keefe, Edward A. O’Neill, Greg Wiederrecht · 1995 · Journal of Biological Chemistry
56. mTOR Signaling in Epilepsy: Insights from Malformations of Cortical Development
    Peter B. Crino · 2015 · Cold Spring Harbor Perspectives in Medicine
57. Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation
    Lifu Wang, Thurl E. Harris, John C. Lawrence · 2008 · Journal of Biological Chemistry
58. Lysosome: The metabolic signaling hub
    Dudley W. Lamming, Liron Bar‐Peled · 2018 · Traffic
59. Regulation of Autophagy by Kinases
    Savitha Sridharan, Kirti Jain, Alakananda Basu · 2011 · Cancers
60. Interaction of RAFT1 with Gephyrin Required for Rapamycin-Sensitive Signaling
    David M. Sabatini, Roxanne K. Barrow, Seth Blackshaw, Patrick E. Burnett, Michael Min-Shyue Lai, Michael E. Field, Ben A. Bahr, Joachim Kirsch, Heinrich Betz, Solomon H. Snyder · 1999 · Science
61. The Biology Behind mTOR Inhibition in Sarcoma
    Xiaolin Wan, Lee J. Helman · 2007 · The Oncologist
62. Immunophilins in the Nervous System
    Solomon H. Snyder, Michael Min-Shyue Lai, Patrick E. Burnett · 1998 · Neuron
63. Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
    Craig A. Goodman, David L. Mayhew, Troy Alan Hornberger · 2011 · Cellular Signalling
64. Autophagy Activation and Protection From Mitochondrial Dysfunction in Human Chondrocytes
    P. López de Figueroa, Martin Lotz, Francisco Javier Blanco, Beatriz Caramés · 2015 · Arthritis & Rheumatology
65. Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.
    Josep Maria Peralba, Linda A. deGraffenried, William E. Friedrichs, Letitia C. Fulcher, Viktor Grünwald, Geoffrey R. Weiss, Manuel M. Hidalgo · 2003 · PubMed
66. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK
    Bela G. Starkman, John D. Cravero, Marcello Del Carlo, Richard F. Loeser · 2005 · Biochemical Journal
67. Microbial Peptidyl-Prolyl cis / trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets
    Can Ünal, Michael Steinert · 2014 · Microbiology and Molecular Biology Reviews
68. Sea urchin genes expressed in activated coelomocytes are identified by expressed sequence tags. Complement homologues and other putative immune response genes suggest immune system homology within the deuterostomes
    L. Courtney Smith, L Chang, Roy J. Britten, Eric H. Davidson · 1996 · The Journal of Immunology
69. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer
    Jeffrey M. Albert, Kwang Woon Kim, Carolyn Cao, Jiahong Lu · 2006 · Molecular Cancer Therapeutics
70. TOR2 Is Part of Two Related Signaling Pathways Coordinating Cell Growth in Saccharomyces cerevisiae
    Stephen B. Helliwell, Isabelle Howald, Nik Barbet, Michael N. Hall · 1998 · Genetics
71. Haven't got a glue: Protein surface variation for the design of molecular glue degraders
    Kozicka, Zuzanna, Thomä, Nicolas Holger · 2021 · Cell Chemical Biology
72. Tuberous Sclerosis Complex
    Francis J. DiMario, Mustafa Şahin, Darius Ebrahimi‐Fakhari · 2015 · Pediatric Clinics of North America
73. mTORC1 signaling in hepatic lipid metabolism
    Jinbo Han, Yiguo Wang · 2017 · Protein & Cell
74. Rapamycin Antifungal Action Is Mediated via Conserved Complexes with FKBP12 and TOR Kinase Homologs in Cryptococcus neoformans
    Maria Cristina Cruz, Lora M. Cavallo, Jenifer M. Görlach, Gary M. Cox, John R. Perfect, Maria Elena Cardenas, Joseph Heitman · 1999 · Molecular and Cellular Biology
75. mTOR signaling in tumorigenesis
    Kai Lin Xu, Pengda Liu, Wenyi Wei · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
76. Rapamycin Inhibits α 1 -Adrenergic Receptor–Stimulated Cardiac Myocyte Hypertrophy but Not Activation of Hypertrophy-Associated Genes
    Marvin O. Boluyt, Jing-Sheng Zheng, Antoine Younès, Xilin Long, Lydia O’Neill, Howard S. Silverman, Edward G. Lakatta, Michael T. Crow · 1997 · Circulation Research
77. The Mammalian Target of Rapamycin Phosphorylates Sites Having a (Ser/Thr)-Pro Motif and Is Activated by Antibodies to a Region near Its COOH Terminus
    Gregory J. Brunn, Patrick Fadden, Timothy Haystead, John C. Lawrence · 1997 · Journal of Biological Chemistry
78. The Secondary Leukemias: Challenges and Research Directions
    Malcolm Anders Smith, Ronald P. McCaffrey, Judith E. Karp · 1996 · JNCI Journal of the National Cancer Institute
79. Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells
    Greg Wiederrecht, Candace J. Sabers, Gregory J. Brunn, Mary M. Martin, Francis J. Dumont, Robert T. Abraham · 1995 · Springer eBooks
80. The central moTOR of metabolism
    Judith Simcox, Dudley W. Lamming · 2022 · Developmental Cell
81. Control of p70 ribosomal protein S6 kinase and acetyl‐CoA carboxylase by AMP‐activated protein kinase and protein phosphatases in isolated hepatocytes
    U. Krause, Luc Bertrand, Louis Hue · 2002 · European Journal of Biochemistry
82. Characterization of S6K2, a novel kinase homologous to S6K1
    Kay K. Lee-Fruman, Calvin Jay Kuo, John Lippincott, Naohiro Terada, John Blenis · 1999 · Oncogene
83. Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells.
    Aimee L. Edinger, Corinne Mary Linardic, Gary Gene Chiang, Craig B. Thompson, Robert T. Abraham · 2003 · PubMed
84. Fragments of ATM Which Have Dominant-Negative or Complementing Activity
    Susan E. Morgan, Christine Marie Lovly, Tej Krishan Pandita, Yosef Shiloh, Michael B. Kastan · 1997 · Molecular and Cellular Biology
85. Activation of pp70/85 S6 Kinases in Interleukin-2-Responsive Lymphoid Cells Is Mediated by Phosphatidylinositol 3-Kinase and Inhibited by Cyclic AMP
    Mercè Monfar, Katherine P. Lemon, Timothy C. Grammer, Lynn A. Cheatham, Jongkyeong Chung, Chris J. Vlahos, John Blenis · 1995 · Molecular and Cellular Biology
86. The role of mTOR in the management of solid tumors: An overview
    Alexios S Strimpakos, Eleni M. Karapanagiotou, M. W. Saif, Kostas Syrigos · 2008 · Cancer Treatment Reviews
87. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family
    Merl F. Hoekstra · 1997 · Current Opinion in Genetics & Development
88. Dual inhibition of phosphatidylinositol 3‐kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin
    Naghma Khan, Farrukh Afaq, Fatima H. Khusro, Vaqar Mustafa Adhami, Yewseok K. Suh, Hasan Mukhtar · 2011 · International Journal of Cancer
89. Signaling Pathways through Which Insulin Regulates CCAAT/Enhancer Binding Protein α (C/EBPα) Phosphorylation and Gene Expression in 3T3-L1 Adipocytes
    Nahid Hemati, Sarah E. Ross, Robin L. Erickson, Guy E. Groblewski, Ormond A. MacDougald · 1997 · Journal of Biological Chemistry
90. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
    Silva, M. Catarina, Nandi, Ghata A., Tentarelli, Sharon, Gurrell, Ian K., Jamier, Tanguy, Lucente, Diane, Dickerson, Bradford C., Brown, Dean G., Brandon, Nicholas J., Haggarty, Stephen J. · 2020 · Nature Communications
91. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis
    Soichi Kobayashi, Takashi Kishimoto, Shigeyuki Kamata, Masayuki Otsuka, Masaru Miyazaki, Hiroshi Ishikura · 2007 · Cancer Science
92. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages
    Andrea M. Woltman, Johan Willem de Fijter, Sylvia W.A. Kamerling, Sandra W. van der Kooij, Lorna Paul, Mohamed R. Daha, Cees van Kooten · 2001 · Blood
93. The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1 Progression
    Vilella-Bach, Montserrat, Nuzzi, Paul, Fang, Yimin, Chen, Jie · 1999 · Journal of Biological Chemistry
94. Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
    Thomas Strömberg, Anna Dimberg, Anna Hammarberg, Kristina Elisabet Carlson, Anders Österborg, Kenneth Nilsson, Helena Jernberg‐Wiklund · 2003 · Blood
95. The evolution of the TOR pathway and its role in cancer
    Elspeth M. Beauchamp, Leonidas C. Platanias · 2012 · Oncogene
96. mTOR regulates cell survival after etoposide treatment in primary AML cells
    Qing Xu, James E. Thompson, Martin P Carroll · 2005 · Blood
97. Rapamycin Activates Autophagy and Improves Myelination in Explant Cultures from Neuropathic Mice
    Sunitha Rangaraju, Jonathan D. Verrier, Irina Madorsky, Jessica Nicks, William A. Dunn, Lucia M. Notterpek · 2010 · Journal of Neuroscience
98. Regulation of Both Glycogen Synthase and PHAS-I by Insulin in Rat Skeletal Muscle Involves Mitogen-activated Protein Kinase-independent and Rapamycin-sensitive Pathways
    Iñaki Azpiazu, Alan R. Saltiel, Anna A DePaoli-Roach, John C. Lawrence · 1996 · Journal of Biological Chemistry
99. Programmed Cell Death Pathways and Current Antitumor Targets
    Ming Tan, Jer Ping Ooi, Nawfal I Ismail, Ahmed Ismail Hassan Moad, Tengku Sifzizul Tengku Muhammad · 2009 · Pharmaceutical Research
100. mTOR function and therapeutic targeting in breast cancer.
     Stephen H Hare, Amanda Harvey · 2017 · PubMed Central